Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators. | Ann Hum Genet | 2017 | 28653770 | PubTator, text mining | PubMed |
| Clinical Applicability of Whole-Exome Sequencing Exemplified by a Study in Young Adults with the Advanced Cryptogenic Cholestatic Liver Diseases. | Gastroenterol Res Pract | 2017 | 28626473 | PubTator, text mining | PubMed |
| Role of the N-acetylation polymorphism in solithromycin metabolism. | Pharmacogenomics | 2017 | 28625123 | PubTator, text mining | PubMed |
| Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia. | CPT Pharmacometrics Syst Pharmacol | 2017 | 28623849 | PubTator, text mining | PubMed |
| Evaluation of ameliorative ability of Silibinin against zidovudine and isoniazid-induced hepatotoxicity and hyperlipidaemia in rats: Role of Silibinin in Phase I and II drug metabolism. | Chem Biol Interact | 2017 | 28619387 | PubTator, text mining | PubMed |
| Identification of enzymes responsible for nitrazepam metabolism and toxicity in human. | Biochem Pharmacol | 2017 | 28606603 | PubTator, text mining | PubMed |
| Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk. | Pharmacol Res Perspect | 2017 | 28603631 | PubTator, text mining | PubMed |
| Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery. | CPT Pharmacometrics Syst Pharmacol | 2017 | 28597978 | PubTator, text mining | PubMed |
| Highlight report: N-acetyltransferase 2 and urinary bladder cancer risk. | Arch Toxicol | 2017 | 28577040 | PubTator, text mining | PubMed |
| Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats. | PLoS One | 2017 | 28575121 | PubTator, text mining | PubMed |
| N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis. | Indian J Med Res | 2017 | 28574024 | PubTator, text mining | PubMed |
| Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics-small molecule drug interactions. | Expert Opin Drug Metab Toxicol | 2017 | 28537216 | PubTator, text mining | PubMed |
| Rabbit N-acetyltransferase 2 genotyping method to investigate role of acetylation polymorphism on N- and O-acetylation of aromatic and heterocyclic amine carcinogens. | Arch Toxicol | 2017 | 28536864 | PubTator, text mining | PubMed |
| Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype. | Arch Toxicol | 2017 | 28523442 | PubTator, text mining | PubMed |
| Glioblastoma-derived cells in vitro unveil the spectrum of drug resistance capability - comparative study of tumour chemosensitivity in different culture systems. | Biosci Rep | 2017 | 28522553 | PubTator, text mining | PubMed |
| Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes. | Arch Toxicol | 2017 | 28516247 | PubTator, text mining | PubMed |
| Architecture of the human interactome defines protein communities and disease networks. | Nature | 2017 | 28514442 | PubTator, text mining | PubMed |
| Endothelial cell-derived matrix promotes the metabolic functional maturation of hepatocyte via integrin-Src signalling. | J Cell Mol Med | 2017 | 28470937 | PubTator, text mining | PubMed |
| Daily Rhythm in Plasma N-acetyltryptamine. | J Biol Rhythms | 2017 | 28466676 | PubTator, text mining | PubMed |
| An in vitro system for measuring genotoxicity mediated by human CYP3A4 in Saccharomyces cerevisiae. | Environ Mol Mutagen | 2017 | 28436563 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=65